The HCPLive gastroesophageal reflux disease page is a comprehensive resource for clinical news and insights on GERD. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for reflux disease, and more.
February 15th 2023
January 12th 2023
Atop already surprising studies that linked their daily use with increased risk of kidney failure, new data has emerged that shows they may also contribute to weakening of the bones.
The US Food and Drug Administration (FDA) has approved dexlansoprazole (Dexilant SoluTab/Takeda Pharmaceuticals), a new formulation for the treatment of heartburn-associated gastroesophageal reflux disease (GERD) in adults age 18 and older.
Raised lesions of dysplatic Barrett's esophagus (BE) are treated with endoscopic mucosal resection (EMR) before ablation. But the procedure causes bleeding in 10% of cases.Mayo Clinic researchers said they found a way to reduce those adverse events.
The LINX Reflux Management System was recently shown to successfully control reflux-related symptoms in patients with gastroesophageal reflux disease (GERD), reducing their need to continue treatment with proton pump inhibitors (PPIs) and other acid-suppression medications.